STATUS: Recruitment completed

SPONSOR: Centre Hospitalier Universitaire de Besancon
LEAD GROUP: GINECO
ENGOT Model: B
TITLE: International validation study of sentinel node biopsy in early cervical cancer
ClinicalTrials.gov ID:  NCT03386734
MaNGO sites (click to see the list)

STATUS: Recruitment completed

SPONSOR: Seagen Inc.
LEAD GROUP: BGOG
ENGOT Model: C
TITLE: A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator’s Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
ClinicalTrials.gov ID:  NCT04697628
MaNGO sites (click to see the list)

STATUS: Recruitment completed

SPONSOR: Merck Sharp & Dohme LLC
LEAD GROUP: NSGO
ENGOT Model: C
TITLE: A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice as Second-Line or Third-Line Treatment for Participants with Recurrent or Metastatic Cervical Cancer
ClinicalTrials.gov ID:  NCT06459180
MaNGO sites (click to see the list)